Experimental and Clinical Pharmacology Graduate Program
New in 2021: Applied Pharmacogenomics Focus for MS
The University of Minnesota College of Pharmacy is launching an innovative Applied Pharmacogenomics Masters Program starting in the Fall of 2021. The program was designed specifically for pharmacists who are interested in health system pharmacogenomic implementation with the flexibility to fit a working schedule.
The Applied Pharmacogenomics MS program will offer a wide range of courses from genetics to bioinformatics to implementation science. Courses will also cover areas of health informatics, pharmacoeconomics, clinical decision support, and ethical and legal issues associated with the application of pharmacogenomics in health care.
In our program, students study pharmacogenomics and implementation science in a highly individualized course of study that is chosen in close consultation with their advisor.
Visit the Department of Experimental and Clinical Pharmacology's coursework page for more information on Applied Pharmacogenomics coursework and credits.
Prepare for your career in clinical and translational research with a PhD or MS degree in Experimental and Clinical Pharmacology.
The Experimental and Clinical Pharmacology graduate program at the University of Minnesota College of Pharmacy is an innovative, interdisciplinary program that trains students to conduct research encompassing methodology from basic and clinical pharmacology perspectives.
Graduates are prepared for distinguished careers in clinical researchThe program was designed specifically for students who are interested in clinical and translational and share our goal of advancing the science of human pharmacology and therapeutics to improve the safe, effective and economical use of drugs by patients.
In our program, students study experimental pharmacotherapy, infectious disease, neuroscience/neuropharmacology, pharmacogenomics, and pharmacometrics in a highly individualized course of study that is chosen in close consultation with their advisor.
The application deadline is Nov. 30, 2021. Students are admitted for fall semester only.
Designated as a
Center of Excellence
for Model-based Drug Development (MBDD)
Our program is designated as a Center of Excellence by Certara.
Our students incorporate analyses and method development using Certara's Phoenix software suite into thesis and research projects.